Irena Krga
Tatjana Ruskovska
Dragan Milenkovic- 1Department of Nutrition, University of California, Davis, Davis, CA, United States
- 2Centre of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia
- 3Faculty of Medical Sciences, Goce Delcev University, Stip, North Macedonia
Editorial on the Research Topic
Plant food bioactives, genomics, and health effects
Different plant food compounds, such as polyphenols, carotenoids, alkaloids, and phytosterols, are widely recognized for their bioactivity and potential role in preventing or delaying the onsets of many chronic diseases, including cardiometabolic and neurodegenerative diseases and cancer (1–4). Various studies have shown the antiinflammatory, antioxidant, vasculoprotective, immunomodulatory, anticarcinogenic, and other biological effects of these bioactives. Still, the exact mechanisms underlying their actions are not fully understood. Emerging data suggest that these compounds exert their biological effects by affecting multiple molecular targets, mainly through different genomic and epigenetic mechanisms (5–8). They seem to act at various levels of cell regulation, most probably simultaneously, affecting DNA methylation and histone modification processes modulating the expression of both protein-coding and non-coding genes and protein expression and activity (9–13). However, studies employing holistic, untargeted approaches that do not only look at the selected targets are relatively rare, and therefore, understanding the overall complex mechanisms of actions of these compounds requires further investigation.
This Research Topic presents recent works examining the role of several plant food bioactives in the prevention and treatment of different chronic diseases by focusing on deciphering the complex molecular mechanisms of their actions. A review by Samota et al. provides a summary of the antidiabetic, antiobesity, cardioprotective, hepatoprotective, and anticancerous activities of anthocyanins, a polyphenol group of compounds regularly consumed in red-, purple- and violet-colored vegetables, fruits, and cereals. The authors also address the importance of factors influencing anthocyanin stability, including various extraction methods, in the bioavailability of these compounds and, ultimately, their biological effects. The multigenomic action of anthocyanin-rich extract from black beans on adipose tissue was demonstrated for the first time by Damián-Medina et al. in an animal model of type 2 diabetes. Using RNAseq and bioinformatic analyses, this study showed that anthocyanin-rich extract modulated the expression of both protein-coding and non-coding genes (miRNAs, lncRNAs, and snRNAs) that were identified as involved in regulating different pathways with notable roles in type 2 diabetes pathogenesis, such as insulin secretion, PI3K signaling, NIN/NF-κB signaling, and endoplasmic reticulum organization. More importantly, these nutrigenomic effects were paralleled by improved blood glucose and inflammatory marker levels, suggesting that the antidiabetic effects of this anthocyanin-rich extract are achieved through complex genomic regulation in the adipose tissue. Transcriptomic modifications in adipose and hepatic tissue were also observed following dietary supplementation with quercetin in the context of metabolic syndrome (Kábelová et al.). In this animal study, quercetin—which is abundantly present in apples, onions, berries, and grapes—was shown to affect the expression of different genes linked with the regulation of lipid and fatty acid metabolism and also the functions associated with metabolic syndrome. Moreover, the authors identified critical regulatory nodes, including PPARG, NOS2, ADIPOQ, and Mir378, and suggested their modulation by quercetin as the potential mechanism underpinning the reduced fat accumulation and improved glucose tolerance observed in animals that are fed a quercetin-enriched diet.
Besides the evidence from mechanistic animal studies, the pleiotropic mode of action of polyphenols was also reported in human subjects (Krga et al.). More specially, the consumption of flavanones in grapefruit juice for 6 months altered the expressions of numerous protein-coding genes and miRNAs in peripheral blood mononuclear cells of postmenopausal women. Moreover, this effect was paralleled by improvements in arterial stiffness, evaluated as pulse wave velocity. By combining various bioinformatic analyses, this study revealed the complex mechanisms underlying the vasculoprotective effects of grapefruit flavanones, including interactions with several transcription factors and cell signaling proteins and modulations in the expression of both mRNAs and miRNAs involved in inflammation, immune response, cell interaction, and motility. Altogether, this results in a global gene expression profile that is inversely correlated with those observed in hypertension and arterial stiffness.
In addition to polyphenols, other plant food bioactive compounds have also been evaluated for their biological effects and underlying mechanisms of actions, particularly in the context of exploring complementary and alternative therapeutic options to conventional drug treatments for chronic diseases. By employing in vitro studies, in silico molecular docking, and enzyme inhibition assessments, Hu et al. showed the potency of the oligopeptides VYGF, GLLGY, and HWP, obtained from fermented rice bran, to inhibit the angiotensin-converting enzyme, suggesting their potential use in managing hypertension. Moreover, they revealed that HWP could also inhibit the activity of pancreatic lipase and potentially be used in the control of obesity. On the other hand, alkaloid leonurine hydrochloride was identified by Wu et al. as a potent antioxidant and hepatoprotective agent in vitro that is promising for potential use against liver damage in alcoholic liver disease. By combining RNA-seq and metabolomic analyses, this study identified modulations of lipid metabolism, particularly glycerophospholipid metabolism, as an essential target through which this alkaloid could mediate its action against this liver disease.
In summary, the results from this Research Topic further support the use of different omics and bioinformatic approaches to tackle the complex, multilevel mode of action of plant food bioactives and provide an understanding of their effects. Future research should involve more multiomics explorations of the actions of these compounds in physiologically relevant conditions in both in vitro and in vivo studies, and particularly human trials in different disease contexts, to obtain a comprehensive picture of the molecular mechanisms underlying the health-promoting properties of these bioactives. Moreover, mechanistic explorations in subjects of varying ethnicity, gender, age, or genetic background will allow to explore the variability in responsiveness to plant food bioactives (14) and pave the way for precision nutrition practices.
Author contributions
IK wrote and TR and DM reviewed the manuscript. All authors approved the final version of the manuscript.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Crowe-White KM, Evans LW, Kuhnle GGC, Milenkovic D, Stote K, Wallace T, et al. Flavan-3-ols and cardiometabolic health: first ever dietary bioactive guideline. Adv Nutr. (2022) 13:2070–83. doi: 10.1093/advances/nmac105
2. Eggersdorfer M, Wyss A. Carotenoids in human nutrition and health. Arch Biochem Biophys. (2018) 652:18–26. doi: 10.1016/j.abb.2018.06.001
3. Ruskovska T, Maksimova V, Milenkovic D. Polyphenols in human nutrition: from the in vitro antioxidant capacity to the beneficial effects on cardiometabolic health and related inter-individual variability - An overview and perspective. Br J Nutr. (2020) 123:241–54. doi: 10.1017/S0007114519002733
4. Krga I, Milenkovic D. Anthocyanins: from sources and bioavailability to cardiovascular-health benefits and molecular mechanisms of action. J Agric Food Chem. (2019) 67:1771–83. doi: 10.1021/acs.jafc.8b06737
5. Ruskovska T, Budić-Leto I, Corral-Jara KF, Ajdžanović V, Arola-Arnal A, Bravo FI, et al. Systematic bioinformatic analyses of nutrigenomic modifications by polyphenols associated with cardiometabolic health in humans—Evidence from targeted nutrigenomic studies. Nutrients. (2021) 13:1–28. doi: 10.3390/nu13072326
6. Ruskovska T, Budić-Leto I, Corral-Jara KF, Ajdžanović V, Arola-Arnal A, Bravo FI, et al. Systematic analysis of nutrigenomic effects of polyphenols related to cardiometabolic health in humans – Evidence from untargeted mRNA and miRNA studies. Ageing Res Rev. (2022) 79: 101649. doi: 10.1016/j.arr.2022.101649
7. Milenkovic D, Ruskovska T. Mechanistic insights into dietary (poly)phenols and vascular dysfunction-related diseases using multi-omics and integrative approaches: machine learning as a next challenge in nutrition research. Mol Aspects Med. (2023) 89:101101. doi: 10.1016/j.mam.2022.101101
8. Ruskovska T, Massaro M, Carluccio MA, Arola-Arnal A, Muguerza B, Vanden Berghe W, et al. Systematic bioinformatic analysis of nutrigenomic data of flavanols in cell models of cardiometabolic disease. Food Funct. (2020) 11:5040–64. doi: 10.1039/D0FO00701C
9. Milenkovic D, Declerck K, Guttman Y, Kerem Z, Claude S, Weseler AR, et al. (–)-Epicatechin metabolites promote vascular health through epigenetic reprogramming of endothelial-immune cell signaling and reversing systemic low-grade inflammation. Biochem Pharmacol. (2020) 173:113699. doi: 10.1016/j.bcp.2019.113699
10. Corral-Jara KF, Nuthikattu S, Rutledge J, Villablanca A, Fong R, Heiss C, et al. Structurally related (–)-epicatechin metabolites and gut microbiota derived metabolites exert genomic modifications via VEGF signaling pathways in brain microvascular endothelial cells under lipotoxic conditions: Integrated multi-omic study. J Proteomics. (2022) 263:104603. doi: 10.1016/j.jprot.2022.104603
11. Milenkovic D, Rodriguez-Mateos A, Lucosz M, Istas G, Declerck K, Sansone R, et al. Flavanol consumption in healthy men preserves integrity of immunological-endothelial barrier cell functions: nutri(epi)genomic analysis. Mol Nutr Food Res. (2022) 66:1–21. doi: 10.1002/mnfr.202100991
12. Krga I, Tamaian R, Mercier S, Boby C, Monfoulet L-E, Glibetic M, et al. Anthocyanins and their gut metabolites attenuate monocyte adhesion and transendothelial migration through nutrigenomic mechanisms regulating endothelial cell permeability. Free Radic Biol Med. (2018) 124:364–79. doi: 10.1016/j.freeradbiomed.2018.06.027
13. Milenkovic D, Krga I, Dinel AL, Morand C, Laye S, Castanon N. Nutrigenomic modification induced by anthocyanin-rich bilberry extract in the hippocampus of ApoE-/- mice. J Funct Foods. (2021) 85:104609. doi: 10.1016/j.jff.2021.104609
14. Nikolic M, Konic Ristic A, González-Sarrías A, Istas G, Urpi-Sarda M, Dall'Asta M, et al. Improving the reporting quality of intervention trials addressing the inter-individual variability in response to the consumption of plant bioactives: quality index and recommendations. Eur J Nutr. (2019) 58:49–64. doi: 10.1007/s00394-019-02069-3
Keywords: plant food bioactives, polyphenols, nutrigenomics, mechanisms of action, biological effects, alkaloids, bioinformatics, health benefits
Citation: Krga I, Ruskovska T and Milenkovic D (2023) Editorial: Plant food bioactives, genomics, and health effects. Front. Nutr. 10:1166149. doi: 10.3389/fnut.2023.1166149
Received: 14 February 2023; Accepted: 21 February 2023;
Published: 08 March 2023.
Edited and reviewed by: Ahmed El-Sohemy, University of Toronto, Canada
Copyright © 2023 Krga, Ruskovska and Milenkovic. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Irena Krga, aWtyZ2EmI3gwMDA0MDt1Y2RhdmlzLmVkdQ==